Attenuated dengue viruses are genetically more diverse than their respective wild-type parents

Abstract Dengue poses a significant burden of individual health, health systems and the economy in dengue endemic regions. As such, dengue vaccine development has been an active area of research. Previous studies selected attenuated vaccine candidates based on plaque size. However, these candidates...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amanda Makha Bifani, Milly M. Choy, Hwee Cheng Tan, Eng Eong Ooi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/e74404e1387b4601ad89e5f5720fa7a9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e74404e1387b4601ad89e5f5720fa7a9
record_format dspace
spelling oai:doaj.org-article:e74404e1387b4601ad89e5f5720fa7a92021-12-02T15:45:20ZAttenuated dengue viruses are genetically more diverse than their respective wild-type parents10.1038/s41541-021-00340-52059-0105https://doaj.org/article/e74404e1387b4601ad89e5f5720fa7a92021-05-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00340-5https://doaj.org/toc/2059-0105Abstract Dengue poses a significant burden of individual health, health systems and the economy in dengue endemic regions. As such, dengue vaccine development has been an active area of research. Previous studies selected attenuated vaccine candidates based on plaque size. However, these candidates led to mixed safety outcome in clinical trials, suggesting it is insufficiently informative as an indicator of dengue virus (DENV) attenuation. In this study, we examined the genome diversity of wild-type DENVs and their attenuated derivatives developed by Mahidol University and tested in phase 1 clinical trials. We found that the attenuated DENVs, in particular the strain under clinical development by Takeda Vaccines, DENV2 PDK53, showed significantly higher genome diversity than its wild-type parent, DENV2 16681. The determinant of genomic diversity was intrinsic to the PDK53 genome as infectious clone of PDK53 showed greater genomic diversity after a single in vitro passage compared to 16681 infectious clone. Similar trends were observed with attenuated DENV1 and DENV4, both of which were shown to be attenuated clinically, but not DENV3 that was not adequately attenuated clinically. Taken together, evidence presented here suggests that genome diversity could be developed into a marker of DENV attenuation.Amanda Makha BifaniMilly M. ChoyHwee Cheng TanEng Eong OoiNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Amanda Makha Bifani
Milly M. Choy
Hwee Cheng Tan
Eng Eong Ooi
Attenuated dengue viruses are genetically more diverse than their respective wild-type parents
description Abstract Dengue poses a significant burden of individual health, health systems and the economy in dengue endemic regions. As such, dengue vaccine development has been an active area of research. Previous studies selected attenuated vaccine candidates based on plaque size. However, these candidates led to mixed safety outcome in clinical trials, suggesting it is insufficiently informative as an indicator of dengue virus (DENV) attenuation. In this study, we examined the genome diversity of wild-type DENVs and their attenuated derivatives developed by Mahidol University and tested in phase 1 clinical trials. We found that the attenuated DENVs, in particular the strain under clinical development by Takeda Vaccines, DENV2 PDK53, showed significantly higher genome diversity than its wild-type parent, DENV2 16681. The determinant of genomic diversity was intrinsic to the PDK53 genome as infectious clone of PDK53 showed greater genomic diversity after a single in vitro passage compared to 16681 infectious clone. Similar trends were observed with attenuated DENV1 and DENV4, both of which were shown to be attenuated clinically, but not DENV3 that was not adequately attenuated clinically. Taken together, evidence presented here suggests that genome diversity could be developed into a marker of DENV attenuation.
format article
author Amanda Makha Bifani
Milly M. Choy
Hwee Cheng Tan
Eng Eong Ooi
author_facet Amanda Makha Bifani
Milly M. Choy
Hwee Cheng Tan
Eng Eong Ooi
author_sort Amanda Makha Bifani
title Attenuated dengue viruses are genetically more diverse than their respective wild-type parents
title_short Attenuated dengue viruses are genetically more diverse than their respective wild-type parents
title_full Attenuated dengue viruses are genetically more diverse than their respective wild-type parents
title_fullStr Attenuated dengue viruses are genetically more diverse than their respective wild-type parents
title_full_unstemmed Attenuated dengue viruses are genetically more diverse than their respective wild-type parents
title_sort attenuated dengue viruses are genetically more diverse than their respective wild-type parents
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/e74404e1387b4601ad89e5f5720fa7a9
work_keys_str_mv AT amandamakhabifani attenuateddenguevirusesaregeneticallymorediversethantheirrespectivewildtypeparents
AT millymchoy attenuateddenguevirusesaregeneticallymorediversethantheirrespectivewildtypeparents
AT hweechengtan attenuateddenguevirusesaregeneticallymorediversethantheirrespectivewildtypeparents
AT engeongooi attenuateddenguevirusesaregeneticallymorediversethantheirrespectivewildtypeparents
_version_ 1718385781935964160